You are here

Public Health

Three doses of mRNA COVID vaccine show advantage against severe outcomes --study

A team led by US Food and Drug Administration (FDA) researchers studying Medicare claims data during the early Omicron SARS-CoV-2 variant months conclude that a third dose of mRNA COVID-19 vaccine provides significant protection against hospitalization and death compared with two doses but wanes substantially after 4 months.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

RSV: Researchers pinpoint markers of more severe cases among children

Respiratory syncytial virus (RSV) remains the top cause of hospitalization among young children, leading to respiratory issues like bronchiolitis and pneumonia. However, the reasons why some children experience only mild symptoms while others suffer from severe disease are not well understood.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Public Health
howdy folks
Page loaded in 1.350 seconds.